期刊文献+

Dynamic optimal strategy for monitoring disease recurrence 被引量:1

Dynamic optimal strategy for monitoring disease recurrence
原文传递
导出
摘要 Surveillance to detect cancer recurrence is an important part of care for cancer survivors.In this paper we discuss the design of optimal strategies for early detection of disease recurrence based on each patient's distinct biomarker trajectory and periodically updated risk estimated in the setting of a prospective cohort study.We adopt a latent class joint model which considers a longitudinal biomarker process and an event process jointly,to address heterogeneity of patients and disease,to discover distinct biomarker trajectory patterns,to classify patients into different risk groups,and to predict the risk of disease recurrence.The model is used to develop a monitoring strategy that dynamically modifies the monitoring intervals according to patients' current risk derived from periodically updated biomarker measurements and other indicators of disease spread.The optimal biomarker assessment time is derived using a utility function.We develop an algorithm to apply the proposed strategy to monitoring of new patients after initial treatment.We illustrate the models and the derivation of the optimal strategy using simulated data from monitoring prostate cancer recurrence over a 5-year period. Surveillance to detect cancer recurrence is an important part of care for cancer survivors. In this paper we discuss the design of optimal strategies for early detection of disease recurrence based on each patient's distinct biomarker trajectory and periodically updated risk estimated in the setting of a prospective cohort study. We adopt a latent class joint model which considers a longitudinal biomarker process and an event process jointly, to address heterogeneity of patients and disease, to discover distinct biomarker trajectory patterns, to classify patients into different risk groups, and to predict the risk of disease recurrence. The model is used to develop a monitoring strategy that dynamically modifies the monitoring intervals according to patients' current risk derived from periodically updated biomarker measurements and other indicators of disease spread. The optimal biomarker assessment time is derived using a utility function. We develop an algorithm to apply the proposed strategy to monitoring of new patients after initial treatment. We illustrate the models and the derivation of the optimal strategy using simulated data from monitoring prostate cancer recurrence over a 5-year period.
出处 《Science China Mathematics》 SCIE 2012年第8期1565-1582,共18页 中国科学:数学(英文版)
基金 supported by National Cancer Institute(Grant No.U01CA079778)
关键词 动态监测 复发 疾病 最佳策略 生物标志物 风险估计 联合模型 最优策略 Keywords biomarker trajectory cancer recurrence surveillance latent class model, optimal strategy, time-dependent hazard
  • 相关文献

参考文献59

  • 1Andersen E W. Composite likelihood and two-stage estimation in family studies. Biostatistics, 2004, 5:15-30.
  • 2Arlen P M, Bianco F, Dahut W L, et al. Prostate-specific antigen working group guidelines on PSA doubling time. J Urology, 2008, 179:2181-2186.
  • 3Arminger G, Clogg C C, Sobel M E. Handbook of Statistical Modeling for the Social and Behavioral Sciences. New York, London: Plenum Press, 1995.
  • 4Bandeen-Roche K, Miglioretti D L, Zeger S L, et al. Latent variable regression for multiple discrete outcomes. J Amer Statist Assoc, 1997, 92:1375-1386.
  • 5Bairey O, Blickstein D, Stark P, et al. Serum CA 125 as a prognostic factor in non-Hodgkin's lymphoma. Leukemian and Lymphoma, 2003, 44:1733-1738.
  • 6Bender D P, Sorosky J I, Buller R E, et al. Serum CA125 is an independent prognostic factor in cervical adenocarci: noma. Amer J Obstet Gynecol, 2003, 189:113-117.
  • 7Berman J M, Cheung R J, Weinberg D S. Surveillance after colorectal cancer resection. The Lancet, 2000, 355:395-399.
  • 8Blumenstein B A, Ellis W J, Ishak L M. The relationship between serial measurements of the level of a bladder tumor associated antigen and the potential for recurrence. J Urology, 1999, 161:57-61.
  • 9Chung H, Flaherty B P, Schafter J. Latent class logistic regression: Application to Marijuana use and attitudes among high school seniors. J Royal Stat Soc Ser A, 2006, 169:723-743.
  • 10Cooper B C, Sood A K, Davis C S, et al. Preoperative CA 125 levels: an independent prognostic factor for epithelial ovarian cancer. Amer College Obstet Gynecol, 2002, 100:59-64.

同被引文献2

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部